ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices

Clinical Trials Search

OR

CurrentAll Trials

LEOPARDS

Trial Details

  • Trial statusCompleted
  • Study email contactLEOPARDS@imperial.ac.uk
  • Chief InvestigatorProf Anthony Gordon
  • Project managerDr Farah Al-Beidh
  • SponsorImperial College London
  • ISRCTN numberISRCTN12776039
  • PhaseIIb

Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis

Design and Objective

This is a double-blind randomised placebo-controlled parallel group trial. It will be conducted in multiple general adult ICUs within the UK. The study will recruit 516 patients.

Key inclusion criteria

- Hypotension, despite adequate intravenous fluid resuscitation, requiring vasopressor infusion AND two of the following: - Fever (>38C) or hypothermia (<36C) - Tachycardia (heart rate >90 bpm) - Tachypnoea (respiratory rate >20 breaths per min or PaCO2 <4.3 kPa) or on mechanical ventilation - Abnormal leukocyte count (>12,000/<4000 cells/mm3)

Study Disclaimer Statement